From May 9th till May 12th 2016 the second ESOC (European Stroke Organisation Conference) took place in Barcelona, Spain. Edo Richard presented encouraging data on the PreDIVA trial, which illustrated the effect of a multidomain intervention on cognitive functioning in general practice. With more than 3000 attendees this was a perfect opportunity to let the world know about PreDIVA. HATICE was also enthusiastically presented in the poster area with posters on the 'baseline characteristics HATICE' and 'blood pressure variability in PreDIVA'.